Pharmacolog i Uppsala AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHLOG-B.ST research report →
Companywww.pharmacolog.com
Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company was founded in 2007 and is based in Uppsala, Sweden.
- CEO
- Lars Gusch
- IPO
- 2015
- Employees
- 10
- HQ
- Uppsala, SE
Price Chart
Valuation
- Market Cap
- $10.70M
- P/E
- 7.93
- P/S
- 1.23
- P/B
- 0.98
- EV/EBITDA
- 3.12
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 52.21%
- Op Margin
- 14.04%
- Net Margin
- 16.84%
- ROE
- 27.24%
- ROIC
- 3.72%
Growth & Income
- Revenue
- $9.94M · -1.76%
- Net Income
- $-18,277,000 · 4.63%
- EPS
- $-1.11 · -19.35%
- Op Income
- $-18,492,000
- FCF YoY
- 15.84%
Performance & Tape
- 52W High
- $1.23
- 52W Low
- $0.02
- 50D MA
- $0.08
- 200D MA
- $0.12
- Beta
- 2.28
- Avg Volume
- 1.12M
Get TickerSpark's AI analysis on PHLOG-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PHLOG-B.ST Coverage
We haven't published any research on PHLOG-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PHLOG-B.ST Report →